Dividends News 16 December 2025

Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s, Inc. (NYSE: DDS) is having one of those “only-in-markets” weeks: the stock recently tagged fresh highs, investors chased a $30 special dividend, and now the share price is digesting both the rally and the dividend mechanics. As of Tuesday,

16 December 2025

Analyst Ratings·Dividends·Earnings Reports·Stock Market

McDonald’s Stock (NYSE: MCD) on Dec. 16, 2025: Dividend Tailwinds, New Franchise Value Rules, and What Analysts Forecast Next

McDonald’s Corporation stock (NYSE: MCD) was under modest pressure in Tuesday’s session, even as investors digested fresh reporting on stricter “value” expectations for franchisees and the company’s latest dividend payout milestone. As of 19:02 UTC on Dec. 16, MCD traded

16 December 2025

Dividends·Financial Forecasts·Investment Analysis·Stock Market

Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts

Amgen Inc. (NASDAQ: AMGN) is in focus on December 16, 2025, as investors weigh a fresh dividend raise, recent regulatory momentum, and a pipeline narrative that stretches from cardiovascular outcomes to the high-stakes obesity race. As of Dec. 16, 2025

16 December 2025

Dividends·Financial Analysis·Investing·Pharma News·Stock Market

Salesforce (CRM) Stock News Today (Dec. 16, 2025): Agentforce Updates, Dividend Spotlight, Analyst Targets, and What Investors Are Watching

Salesforce, Inc. (NYSE: CRM) stock is back in focus on Tuesday, December 16, 2025, as investors weigh a fresh round of “Agentforce” product ecosystem headlines against a still-evolving AI monetization story and Wall Street’s latest price targets. As of Dec.

16 December 2025

Analyst Insights·Dividends·Salesforce News·Stock Market

Pfizer Forecasts Flat 2026 Sales and Lower Profit as COVID Demand Falls; PFE Dividend Remains $0.43

Pfizer’s latest outlook is setting the tone for how investors may view the drugmaker’s post-pandemic transition in 2026: steady underlying growth ambitions, but a near-term financial “air pocket” as COVID-19 revenue continues to shrink and several products face patent and

16 December 2025

Dividends·Financial News·Pharmaceuticals·Stock Market

Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025

Bristol-Myers Squibb Company (NYSE: BMY) is back in the spotlight on December 16, 2025, with the stock trading around $54.29, up roughly 3.6% on the session as optimism builds around Wall Street upgrades, a newly announced dividend increase, and a

16 December 2025

Analyst Ratings·Dividends·Investing·Pharmaceutical Industry·Stock Market

Pfizer Stock (PFE) Today, Dec. 16, 2025: 2026 Guidance Call Looms as Analysts Weigh Dividend, Deal Flow, and Policy Risks

Pfizer Inc. (NYSE: PFE) heads into Tuesday, December 16, 2025 with a familiar “big pharma” cocktail of catalysts: an imminent guidance event, a high dividend yield, fresh dealmaking in hot therapeutic areas (immunology and obesity), and a regulatory backdrop that

16 December 2025

Dividends·Financial News·Investment Analysis·Pharmaceuticals·Stock Market

Procter & Gamble Stock (PG) News Today: Price Rally Extends, Leadership Shifts, Dividend Outlook and Analyst Forecasts (December 16, 2025)

December 16, 2025 — The Procter & Gamble Company (NYSE: PG) is back in the market’s good graces after a choppy year for consumer staples. PG shares finished the latest session up 1.60% at $145.13, extending the stock’s winning streak

16 December 2025

Analyst Insights·Company News·Dividends·Investment Strategies·Stock Market

HSBC Stock News Today (Dec. 16, 2025): Hang Seng Buyout Timeline, Dividend Focus, Legal Overhang — and What Analysts Forecast Next

HSBC Holdings plc stock is in focus on December 16, 2025, as investors weigh a cluster of developments that cut across capital returns, strategy, and risk. The headline driver remains HSBC’s proposed privatisation of Hang Seng Bank, which comes with

16 December 2025

Banking·Dividends·Financial News·Investment Analysis·Stock Market

SATS Ltd Stock (SGX:S58): Share Price, Buybacks, Dividend and Analyst Targets in Focus on 16 Dec 2025

SATS Ltd shares are back in the spotlight on 16 December 2025, as investors weigh a mix of near-term market momentum and company-specific catalysts—most notably strong cargo-led earnings, a higher interim dividend, and ongoing share buybacks, alongside operational and commercial

16 December 2025

Dividends·Financial News·Investment Analysis·Share Buybacks·Stock Market

OCBC Bank Stock (SGX: O39) Hits Fresh All‑Time High on Dec. 16, 2025: Latest News, Dividend Outlook, and Analyst Forecasts

SINGAPORE (Dec. 16, 2025) — Shares of Oversea-Chinese Banking Corporation Limited (OCBC), one of Singapore’s three banking giants and a major Southeast Asian lender, surged to a new intraday record of S$19.44 in late-morning trade on Tuesday, Dec. 16, 2025,

16 December 2025

Banking·Dividends·Investment Analysis·Singapore Stocks·Stock Market

Macquarie Group Ltd (ASX: MQG) Stock News Today: Share Price Action, Dividend Countdown, and Analyst Forecasts (16 December 2025)

Macquarie Group Ltd (ASX: MQG) shares hovered around the psychologically important A$200 level on Tuesday, 16 December 2025, as investors weighed a near-term income catalyst (the interim dividend payment due 17 December) against mixed technical signals and a still-active debate

16 December 2025

Analyst Reports·Dividends·Financial News·Investing·Stock Market